Clinical Trials
Muscle Strength in Women
The majority of creatine research historically focused on young male athletes. That changed. A 2021 systematic review and meta-analysis examined randomised controlled trials specifically in older females. The finding: creatine combined with resistance training produced significant gains in muscle strength and lean body mass versus training alone — particularly in programmes sustained beyond 24 weeks.
The Impact of Clinical Proof
This meta-analysis confirms that creatine is not a young person's supplement. The women in these trials were post-menopausal. The results were consistent. For women over 40 already training, creatine makes the work count for more.
dos Santos et al., Nutrients, 2021
Brain Creatine and Cognitive Function in Menopausal Women
CONCRET-MENOPA was the first randomised controlled trial to examine creatine supplementation specifically in peri- and post-menopausal women. 36 women, mean age 50.1, supplemented for 8 weeks. The creatine group saw a 1.2% improvement in reaction time while the placebo group declined by 6.6%. Frontal brain creatine levels increased 0.9% versus a 16.4% decline in placebo.
The Impact of Clinical Proof
This is the study that changed the conversation. It demonstrated that creatine does not just support muscles — it measurably supports brain energy in menopausal women. The results also showed improved serum lipid profiles and a trend toward reduced mood swing severity.
Korovljev et al., Journal of the American Nutrition Association, 2025
Cognitive Function Across Adults
A 2024 meta-analysis examined 16 randomised controlled trials on creatine and cognitive function in adults. The pooled findings showed improvements in three areas: memory, attention, and information processing speed. These are the exact cognitive domains most affected during perimenopause and menopause.
The Impact of Clinical Proof
Brain fog is not a vague complaint — it maps onto measurable cognitive functions. This meta-analysis confirms creatine supports precisely the areas women in midlife report losing. The evidence base is broad and growing.
Chen et al., Frontiers in Nutrition, 2024
Bone Health in Post-Menopausal Women
A 2-year randomised controlled trial followed 237 post-menopausal women taking daily creatine combined with supervised exercise. The study confirmed long-term safety and practicality of daily creatine dosing in this population, with supportive findings for bone health maintained through preserved lean mass.
The Impact of Clinical Proof
Two years. 237 women. Post-menopausal. This is not a short pilot study — it is one of the longest creatine trials conducted in women, and it confirmed that daily supplementation is both safe and sustainable in exactly the population CLERA is built for.
Chilibeck et al., 2023
Strength in Older Adults
A 2024 meta-analysis of 20 randomised controlled trials — 69% female participants — found that creatine intake combined with exercise significantly improved 1RM strength in older adults, with a mean increase of 2.12 kg versus placebo (p=0.001).
The Impact of Clinical Proof
Measurable. Replicable. Statistically significant. Across 20 trials and over a thousand participants, the majority of them women, creatine consistently improved functional strength in older adults.
PMC meta-analysis, 2024
Safety in Women
A systematic review and meta-analysis examined all available evidence on creatine monohydrate supplementation in females. The conclusion: no adverse outcomes were identified across any female life stage. Creatine monohydrate has one of the longest and cleanest safety records of any supplement ingredient.
The Impact of Clinical Proof
Every supplement makes claims. Very few have a dedicated safety review confirming zero adverse effects specifically in women. CLERA contains one ingredient — and that ingredient has been cleared across every study that has examined it in the female population.
De Guingand et al., Nutrients, 2020
Creatine Across the Female Lifespan
A 2025 narrative review published in the Journal of the International Society of Sports Nutrition confirmed creatine's benefits across the entire female lifespan — and noted that zero perimenopausal-specific RCTs existed before 2025. The review called for urgent research into creatine for women in midlife, citing the gap between evidence and clinical practice.
The Impact of Clinical Proof
The scientific community is now formally recognising what CLERA was built around: women in perimenopause and menopause have been overlooked by creatine research for decades. That is changing — and the early evidence is compelling.
Smith-Ryan et al., Journal of the International Society of Sports Nutrition, 2025